Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments

Stock Information for Femasys Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Femasys Inc.

Femasys Announces Infertility Clinic Customers from Coast to Coast
Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed® for over $1.3M in Spanish Market
Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube Check
Femasys to Exhibit at The Canadian Fertility and Andrology Society's 70th Annual Meeting
Femasys to Participate in Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference
Femasys Announces CE Mark and Canadian Approval for FemVue® MINI, a Fallopian Tube Assessment Solution
Femasys Hosts Congresswoman Lucy McBath at Georgia Headquarters
Femasys Inc. at August 20th Virtual Investor Summit Microcap Event

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.